Compare CCTG & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CCTG | GCTK |
|---|---|---|
| Founded | 1993 | 2001 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0M | 3.0M |
| IPO Year | 2022 | 2011 |
| Metric | CCTG | GCTK |
|---|---|---|
| Price | $0.89 | $0.33 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 8.4M | 404.1K |
| Earning Date | 12-23-2025 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.65 |
| Revenue | N/A | ★ $589,462.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.12 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.08 | $0.29 |
| 52 Week High | $5.64 | $14.14 |
| Indicator | CCTG | GCTK |
|---|---|---|
| Relative Strength Index (RSI) | 52.54 | 31.05 |
| Support Level | $0.27 | $0.29 |
| Resistance Level | $1.24 | $0.73 |
| Average True Range (ATR) | 0.26 | 0.03 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 16.59 | 9.47 |
CCSC Technology International Holdings Ltd along with its subsidiaries is involved in the sale, design, and manufacturing of interconnect products, including connectors, cables, and wire harnesses. Its products include customized interconnect products, including connectors, cables, and harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas, Asia, and Others.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.